Jundishapur Journal of Microbiology

Published by: Kowsar

Distribution and Drug Susceptibility of Candida spp. Associated With Female Genital Tract Infection, Chongqing, China

Xiaodong Luo 1 , * , Xiaojing Dong 1 and Zhi Pen 1
Authors Information
1 Department of Obstetrics and Gynecology, Second Affiliate Hospital, Chongqing University of Medical Sciences, Chongqing, China
Article information
  • Jundishapur Journal of Microbiology: October 2016, 9 (10); e60101
  • Published Online: September 8, 2015
  • Article Type: Research Article
  • Received: July 23, 2014
  • Revised: February 9, 2015
  • Accepted: March 4, 2015
  • DOI: 10.5812/jjm.19386

To Cite: Luo X, Dong X, Pen Z. Distribution and Drug Susceptibility of Candida spp. Associated With Female Genital Tract Infection, Chongqing, China, Jundishapur J Microbiol. 2016 ; 9(10):e60101. doi: 10.5812/jjm.19386.

Abstract
Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Nurbhai M, Grimshaw J, Watson M, Bond CM, Mollison JA, Ludbrook A. Oral versus intra‐vaginal imidazole and triazole anti‐fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Libr. 2007; 17(4)
  • 2. Inigo M, Peman J, Del Pozo JL. Antifungal activity against Candida biofilms. Int J Artif Organs. 2012; 35(10): 780-91[DOI][PubMed]
  • 3. Taff HT, Mitchell KF, Edward JA, Andes DR. Mechanisms of Candida biofilm drug resistance. Future Microbiol. 2013; 8(10): 1325-37[DOI][PubMed]
  • 4. Sadeghi Nejad B, Rajabi M, Zarei Mamoudabadi A, Zarrin M. In vitro anti-candida activity of the hydroalcoholic extracts of heracleum persicum fruit against phatogenic candida species. Jundishapur J Microbiol. 2014; 7(1)[DOI][PubMed]
  • 5. Shokohi T, Bandalizadeh Z, Hedayati MT, Mayahi S. In vitro antifungal susceptibility of Candida species isolated from oropharyngeal lesions of patients with cancer to some antifungal agents. Jundishapur J Microbiol. 2011; 4(2): 19-26
  • 6. Clinical and Laboratory Standards Institute . Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard M27-A3. 2008;
  • 7. Clinical and laboratory standard institute . reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard- third edition M27-S3. 2008;
  • 8. Mendling W, Brasch J. Guideline vulvovaginal candidosis (2010) of the german society for gynecology and obstetrics, the working group for infections and infectimmunology in gynecology and obstetrics, the german society of dermatology, the board of german dermatologists and the german speaking mycological society 2012;
  • 9. Wang Y, Huang H, LI J, Wen XD, Jiang YY. An update on drug resistance of fungal pathogens. Pharm Care and Res. 2009; 3: 5
  • 10. Rathod SD, Buffler PA. Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented. BMC Womens Health. 2014; 14(1): 43[DOI][PubMed]
  • 11. Filioti J, Spiroglou K, Panteliadis CP, Roilides E. Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome. Intensive Care Med. 2007; 33(7): 1272-83[DOI][PubMed]
  • 12. Liu XP, Fan SR, Peng YT, Zhang HP. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012. J Mycol Med. 2014; 24(2): 106-11[DOI][PubMed]
  • 13. Xu QR, Yan L, Lv QZ, Zhou M, Sui X, Cao YB, et al. Molecular genetic techniques for gene manipulation in Candida albicans. Virulence. 2014; 5(4): 507-20[DOI][PubMed]
  • 14. Vijaya D, Dhanalakshmi TA, Kulkarni S. Changing trends of vulvovaginal candidiasis. J Lab Physicians. 2014; 6(1): 28-30[DOI][PubMed]
  • 15. Mahmoudi Rad M, Zafarghandi A, Amel Zabihi M, Tavallaee M, Mirdamadi Y. Identification of Candida species associated with vulvovaginal candidiasis by multiplex PCR. Infect Dis Obstet Gynecol. 2012; 2012: 872169[DOI][PubMed]
  • 16. Li J, Fan SR, Liu XP, Li DM, Nie ZH, Li F, et al. Biased genotype distributions of Candida albicans strains associated with vulvovaginal candidosis and candidal balanoposthitis in China. Clin Infect Dis. 2008; 47(9): 1119-25[DOI][PubMed]
  • 17. Spence D. Candidiasis (vulvovaginal). BMJ Clin Evid. 2010 Jan 5;2010.; [PubMed]
  • 18. Le J. Obstetrics and gynecology [in Chinese]. 2004;
  • 19. Linhares LM, Witkin SS, Miranda SD, Fonseca AM, Pinotti JA, Ledger WJ. Differentiation between women with vulvovaginal symptoms who are positive or negative for Candida species by culture. Infect Dis Obstet Gynecol. 2001; 9(4): 221-5[DOI][PubMed]
  • 20. Nett JE. Future directions for anti-biofilm therapeutics targeting Candida. Expert Rev Anti Infect Ther. 2014; 12(3): 375-82[DOI][PubMed]
  • 21. Hsu CC, Lai WL, Chuang KC, Lee MH, Tsai YC. The inhibitory activity of linalool against the filamentous growth and biofilm formation in Candida albicans. Med Mycol. 2013; 51(5): 473-82[DOI][PubMed]
  • 22. Buitron Garcia-Figueroa R, Araiza-Santibanez J, Basurto-Kuba E, Bonifaz-Trujillo A. Candida glabrata: an emergent opportunist in vulvovaginitis. Cir Cir. 2009; 77(6): 423-7[PubMed]
  • 23. Peman J, Canton E, Quindos G, Eraso E, Alcoba J, Guinea J, et al. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother. 2012; 67(5): 1181-7[DOI][PubMed]
  • 24. Gualco L, Debbia EA, Bandettini R, Pescetto L, Cavallero A, Ossi MC, et al. Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults. Int J Antimicrob Agents. 2007; 29(2): 179-84[DOI][PubMed]
  • 25. Diba K, Namaki A, Ayatolahi H, Hanifian H. Rapid identification of drug resistant Candida species causing recurrent vulvovaginal candidiasis. Med Mycol J. 2012; 53(3): 193-8[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments